| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GridAI Technologies Corp. | Director | Common Stock | 40,000 | $125,200 | $3.13 | 01 Jan 2026 | Direct |
| LIXTE BIOTECHNOLOGY HOLDINGS, INC. | CEO and Chairman of the Board, Director | Options to Purchase Common Stock | 350,000 | 03 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ENTO | GridAI Technologies Corp. | 01 Jan 2026 | 1 | $0 | 4 | Director | 05 Jan 2026, 16:57 |
| ENTO | Entero Therapeutics, Inc. | 11 Aug 2025 | 0 | $0 | 3 | Director | 18 Aug 2025, 18:58 |
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | 03 Jul 2025 | 1 | $0 | 4 | CEO and Chairman of the Board, Director | 09 Jul 2025, 18:37 |
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | 16 Jun 2025 | 0 | $0 | 3 | CEO and Chairman of the Board, Director | 18 Jun 2025, 14:32 |